We are live on ! Find out more
JP

Jana Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 4.95%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+4.95%
3 Year Est. Return
+36.05%
5 Year Est. Return
+49.5%
10 Year Est. Return
+209.08%
AUM
$5.7B
AUM Growth
-$7.86M
Cap. Flow
-$347M
Cap. Flow %
-6.09%
Top 10 Hldgs %
65.07%
Holding
67
New
18
Increased
17
Reduced
8
Closed
22

Sector Composition

1 Industrials 15.33%
2 Consumer Staples 13.57%
3 Healthcare 13.38%
4 Communication Services 7.19%
5 Technology 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
26
Dell
DELL
$260B
$41.2M 0.72%
2,672,428
-8,102,241
-75% -$116M
YUM icon
27
Yum! Brands
YUM
$41.2B
$40.1M 0.7%
+633,101
New +$39.8M
MAT icon
28
CALL
Mattel
MAT
$4.17B
$37.2M 0.65%
+1,350,000
New +$41.1M
ZAYO
29
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$33.7M 0.59%
+1,026,541
New +$33.6M
SEM
30
DELISTED
Select Medical
SEM
$30.1M 0.53%
4,219,427
+699,423
+20% +$4.87M
VVV icon
31
Valvoline
VVV
$5.1B
$28.4M 0.5%
1,319,727
+270,027
+26% +$5.72M
TSLA icon
32
PUT
Tesla
TSLA
$1.44T
$21.4M 0.37%
+1,500,000
New +$19.7M
FCE.A
33
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$14.7M 0.26%
+706,059
New +$14.3M
XLF icon
34
CALL
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$13.9M 0.24%
600,000
+100,000
+20% +$2.15M
BFH icon
35
Bread Financial
BFH
$4B
$13.6M 0.24%
+74,424
New +$12.9M
SAGE
36
DELISTED
Sage Therapeutics
SAGE
$10.1M 0.18%
198,406
+87,279
+79% +$4.11M
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.9B
$9.01M 0.16%
128,121
+47,996
+60% +$3.41M
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.36B
$8.69M 0.15%
301,243
+151,991
+102% +$4.02M
INCY icon
39
Incyte
INCY
$23.5B
$8.69M 0.15%
86,616
+28,231
+48% +$2.75M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.5B
$7.78M 0.14%
93,923
+41,033
+78% +$3.53M
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7.51M 0.13%
67,198
+25,598
+62% +$3.08M
DERM
42
DELISTED
Dermira, Inc.
DERM
$7.33M 0.13%
241,810
+92,353
+62% +$2.98M
NBIX icon
43
Neurocrine Biosciences
NBIX
$17B
$7.02M 0.12%
181,296
+85,086
+88% +$3.85M
RDUS
44
DELISTED
Radius Health, Inc.
RDUS
$6.55M 0.11%
172,310
+79,916
+86% +$3.8M
PBYI icon
45
Puma Biotechnology
PBYI
$436M
$4.38M 0.08%
142,727
+66,653
+88% +$2.88M
BKNG icon
46
Booking.com
BKNG
$141B
-2,635,225
Closed -$155M
CCEP icon
47
Coca-Cola Europacific Partners
CCEP
$45.9B
-5,149,436
Closed -$205M
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.19T
-3,920,460
Closed -$152M
GPK icon
49
Graphic Packaging
GPK
$3.17B
-10,280,060
Closed -$144M
HPE icon
50
Hewlett Packard
HPE
$61.5B
-11,738,113
Closed -$155M

Similar funds

Jana Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Jana Partners held 67 positions worth $5.7B, down 0.14% from $5.71B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Jana Partners withdrew a net $347M in Q4 2016, closing 22 positions and reducing 8 holdings. Its most notable exit was Johnson Controls International, an estimated $260M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Jana Partners opened a new position in Salesforce worth $217M.

  • Jana Partners's largest Q4 2016 buy was Salesforce: 3,169,289 shares worth $217M.
  • Jana Partners added most to HD Supply Holdings, Inc. in Q4 2016, an estimated $227M increase.
  • Jana Partners's biggest Q4 2016 reduction was Conagra Brands, cutting an estimated $189M.
  • Jana Partners fully exited Johnson Controls International in Q4 2016, selling an estimated $260M.
  • Jana Partners's ten largest holdings make up 65% of its $5.7B portfolio in Q4 2016.
  • Jana Partners opened 18 new positions and closed 22 in Q4 2016.
  • Jana Partners's portfolio value fell 0.14% quarter-over-quarter to $5.7B.

Based on Jana Partners's 13F filing for Q4 2016, filed 14 Feb 2017.